Vela Technologies PLC - Bradford, England-based investment firm focused on early-stage and pre-IPO disruptive technology investments - Notes announcement by Conduit Pharmaceuticals Ltd that it intends to become a publicly traded company on the Nasdaq in the US through a merger with special purpose acquisition firm Murphy Cannon Acquisition Corp. The deal is expected to generate USD149.7 million worth of proceeds for Conduit. Vela holds an interest in the commercialisation of AZD1656, a possible Covid-19 treatment, and one of Conduit's assets.
Current stock price: 0.028 pence, closing 50% higher in London on Wednesday
12-month change: down 54%
By Heather Rydings; heatherrydings@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.


(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.


(Alliance News) - Vela Technologies PLC on Thursday reported an increase to its portfolio value but said the markets "stubbornly fail to reflect the e...


(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.


(Alliance News) - Vela Technologies PLC on Thursday reported an increase to its portfolio value but said the markets "stubbornly fail to reflect the e...


Vela Technologies PLC - Bingley-based early stage-focused technology investor - At June 30, says value of total assets is GBP2.8 million, down from GB...


(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.


(Sharecast News) - Vela Technologies, an AIM-listed company focussed on early-stage and pre-IPO disruptive technology investments, reported a signific...


SEOUL, July 19 (Reuters) - Airlines face their longest ever waits for engine maintenance with demand likely to peak in 2026, according to consultanc...